Search filters

List of works by Elaine Hylek

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

scientific article published on 9 May 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

scientific article published on 15 September 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

scientific article published on 15 September 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

scientific article published on 15 September 2017

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary

scientific article

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary

scientific article published on 15 September 2017

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

scientific article published on 21 October 2017

A response to - There's madness in their methods

A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy

scientific article published on 01 April 2007

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

scientific article published in The Journal of the American Medical Association

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

scientific article

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

scientific article (publication date: 16 November 2004)

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

scientific article published on August 2006

American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association

scientific article

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 01 October 2014

Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article published on 22 December 2016

Anticoagulation therapy for atrial fibrillation

scientific article published on 08 February 2013

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

scientific article (publication date: 26 November 2003)

Antithrombotic prophylaxis in elderly patients with atrial fibrillation

scientific article published on 28 September 2009

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

scientific article published on February 2012

Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician

scientific article published on 21 September 2008

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

scientific article published on 09 July 2015

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

scientific article published in March 2010

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

scientific article published on 25 July 2013

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

scientific article published on 9 June 2015

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

scientific article published on 03 July 2019

Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation

scientific article published on 30 January 2019

Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

scientific article published on 01 August 2018

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

scientific article published on 02 February 2016

Bleeding risk assessment and management in atrial fibrillation patients

article by Laurent Fauchier et al published 2011 in Thrombosis and Haemostasis

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

scientific article published on May 2011

Bleeding risk on warfarin among elderly patients with atrial fibrillation

scientific article published in March 2010

Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)

scientific article published on 23 February 2019

Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

scientific article published on December 2015

Brand name versus generic warfarin: a systematic review of the literature

scientific article published on April 2011

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

scientific article published on 30 April 2020

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

scientific article published in September 2017

Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis

scientific article published in March 2003

Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation

scientific article published on 06 June 2018

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

scientific article published on 4 February 2016

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.

scientific article published on 4 February 2016

Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial

scientific article published on 6 November 2017

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article published on 28 September 2014

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial

scientific article published on 12 December 2014

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

scientific article published on 14 September 2015

Clopidogrel, genetics, and drug responsiveness

scientific article published in January 2009

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status

scientific article published on 10 January 2013

Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors

scientific article published on August 2003

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

article

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

scientific article published on 26 July 2011

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

scientific article published on 24 May 2007

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation

scientific article published on 07 January 2020

Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum

scientific article published on 17 June 2008

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

scientific article published on June 2016

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort

scientific article published on June 2015

Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)

scientific article published on 28 April 2020

Disparate stroke rates on warfarin among contemporaneous cohorts with atrial fibrillation: potential insights into risk from a comparative analysis of SPORTIF III versus SPORTIF V.

scientific article published on 14 August 2008

Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?

scientific article

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

scientific article

Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination

scientific article

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

scientific article

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article published in November 2018

Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)

scientific article published on 12 July 2020

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

scientific article published on 12 September 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

scientific article (publication date: 11 September 2003)

Effectiveness of warfarin among patients with cancer

scientific article

Effects of apixaban compared with warfarin as gain in event-free time - a novel assessment of the results of the ARISTOTLE trial

scientific article published on 07 November 2019

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial

scientific article published on 21 July 2017

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

scientific article

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial

scientific article

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

scientific article published on 2 May 2013

Epidemiology of subtherapeutic anticoagulation in the United States

scientific article published on 22 September 2009

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

scientific article published in February 2003

Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

scientific article published on 16 April 2020

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

scientific article

Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article

Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute

scientific article

Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification

scientific article published on March 2011

Gaps in monitoring during oral anticoagulation: insights into care transitions, monitoring barriers, and medication nonadherence

scientific article

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

scientific article

Genetic testing for warfarin dosing? Not yet ready for prime time

scientific article published in February 2008

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

scientific article

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

scientific article published on 07 October 2014

High blood pressure while taking antithrombotic medication is associated with an increased risk of developing intracranial haemorrhage

scientific article published on August 25, 2010

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

scientific article

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

scientific article published on 19 September 2013

Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23-25, 2008, Sao Paulo, Brazil

scientific article published on 26 March 2009

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil

scientific article published in August 2011

Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil

scientific article published in July 2012

Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil

scientific article published in July 2013

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.

scientific article

How the doctor got gagged

scientific article published in The Journal of the American Medical Association

Identifying major hemorrhage with automated data: results of the Veterans Affairs study to improve anticoagulation (VARIA).

scientific article

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

scientific article published on 7 February 2015

Impaired platelet nitric oxide response in patients with new onset atrial fibrillation

scientific article published on 23 October 2014

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)

scientific article

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation

scientific article published on 25 July 2018

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling

scientific article

Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial

scientific article published on 01 April 2019

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin

scientific article published on 01 July 2019

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

article

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation

scientific article

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

scientific article

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry

scientific article published on July 2017

Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation

scientific article published on 26 November 2007

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

scientific article published on 13 April 2018

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

scientific article published on 3 April 2013

Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation

scientific article

Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology

scientific article published on 01 May 2014

Nonadherence with INR monitoring and anticoagulant complications

scientific article published on 22 June 2013

North American Thrombosis Forum, AF Action Initiative Consensus Document

scientific article published on May 2016

Obesity begets atrial fibrillation: a contemporary summary

scientific article

Oral anticoagulant therapy for patients with atrial fibrillation--an update

scientific article published on 21 September 2008

Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

scientific article

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

scientific article published on 19 May 2017

Organizational characteristics of high- and low-performing anticoagulation clinics in the Veterans Health Administration

scientific article

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry

scientific article

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

scientific article published on 13 December 2019

Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.

scientific article published on 13 May 2009

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

scientific article published in October 2011

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

scientific article published on 21 November 2019

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

scientific article published on April 2015

Patterns of oral anticoagulation use with cardioversion in clinical practice

scientific article published on 26 June 2020

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

scientific article published on 28 August 2016

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

scientific article

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF

scientific article published on 01 September 2018

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article

Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieu.

scientific article published on 2 July 2015

Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation

scientific article

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation

scientific article published on 01 August 2018

Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry

scientific article

Reducing the risk for stroke in patients who have atrial fibrillation

scientific article published on May 2008

Reexamining the recommended follow-up interval after obtaining an in-range international normalized ratio value: results from the Veterans Affairs study to improve anticoagulation

scientific article published on 10 February 2011

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

scientific article

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

scientific article

Risk of thromboembolism with short-term interruption of warfarin therapy

scientific article

Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).

scientific article published on 23 November 2010

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials

scientific article published on 08 June 2020

Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy

scientific article published in August 2016

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHADS-VASc Scores: Findings From the ORBIT-AF I and II Registries

article published in 2018

Stroke prevention in atrial fibrillation: Closing the gap

scientific article published on 25 October 2018

Stroke prevention in atrial fibrillation: current status and near-future directions

scientific article published on September 2011

Stroke prevention in elderly patients with atrial fibrillation

scientific article (publication date: 11 August 2007)

The "gender gap" in authorship of academic medical literature--a 35-year perspective

scientific article published in July 2006

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

scientific article published on 25 February 2016

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations

scientific article published on 31 December 2018

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

scientific article

The business case for quality improvement: oral anticoagulation for atrial fibrillation

scientific article published on 28 June 2011

The need for new oral anticoagulants in clinical practice

scientific article published on August 2009

The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation

scientific article

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

scientific article

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

scientific article

The risk of hemorrhage among patients with warfarin-associated coagulopathy

scientific article published on 26 January 2006

Therapeutic Potential of Oral Factor Xa Inhibitors

scientific article published on December 23, 2010

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

scientific article published on 9 June 2018

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study

scientific article published in August 2008

Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation

scientific article published on 9 March 2006

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

scientific article published in November 2017

Trends in anticoagulation management across community-based practices in the United States: the Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) study

scientific article published on August 2003

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

scientific article

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

scientific article published on 16 July 2013

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

scientific article published on 01 October 2018

Venous thromboembolism after joint replacement in older male veterans with comorbidity

scientific article

Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement

scientific article published on April 1, 2013

Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility

scientific article published on 12 September 2011

Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population

scientific article published in June 2005